Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suprascapular nerve corticosteroid block versus pulsed radiofrequency for chronic shoulder pain
2017-004612-19Phase 4Active
- Sponsor
- Hospital de la Santa Creu i Sant Pau Research Institute
- Start
- Jan 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of triamcinolone acetonide in Chronic shoulder pain (2 arms), sponsored by Hospital de la Santa Creu i Sant Pau Research Institute. Primary endpoint: Shoulder Pain and Disability Index (SPADI). Started Jan 2018; status: active.
02
Drugs
triamcinolone acetonide
03
Conditions
Chronic shoulder pain
Beyond the preview
Go deeper on 2017-004612-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-004612-19.